- Home
- WTTR vs XNCR Comparison
WTTR vs XNCR Comparison
Compare WTTR & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTTR
- XNCR
- Stock Information
- Founded
- WTTR 2016
- XNCR 1997
- Country
- WTTR United States
- XNCR United States
- Employees
- WTTR N/A
- XNCR N/A
- Industry
- WTTR Oilfield Services/Equipment
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- WTTR Energy
- XNCR Health Care
- Exchange
- WTTR Nasdaq
- XNCR Nasdaq
- Market Cap
- WTTR 1.4B
- XNCR 1.5B
- IPO Year
- WTTR 2017
- XNCR 2013
- Fundamental
- Price
- WTTR $13.46
- XNCR $24.79
- Analyst Decision
- WTTR Strong Buy
- XNCR Strong Buy
- Analyst Count
- WTTR 2
- XNCR 9
- Target Price
- WTTR $13.75
- XNCR $36.33
- AVG Volume (30 Days)
- WTTR 740.9K
- XNCR 627.6K
- Earning Date
- WTTR 11-05-2024
- XNCR 11-06-2024
- Dividend Yield
- WTTR 2.08%
- XNCR N/A
- EPS Growth
- WTTR 11.32
- XNCR N/A
- EPS
- WTTR 0.59
- XNCR N/A
- Revenue
- WTTR $1,477,888,000.00
- XNCR $85,164,000.00
- Revenue This Year
- WTTR N/A
- XNCR N/A
- Revenue Next Year
- WTTR $6.32
- XNCR $89.22
- P/E Ratio
- WTTR $22.78
- XNCR N/A
- Revenue Growth
- WTTR N/A
- XNCR N/A
- 52 Week Low
- WTTR $6.99
- XNCR $15.31
- 52 Week High
- WTTR $15.14
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- WTTR 45.90
- XNCR 56.01
- Support Level
- WTTR $13.32
- XNCR $23.78
- Resistance Level
- WTTR $14.88
- XNCR $25.54
- Average True Range (ATR)
- WTTR 0.42
- XNCR 1.05
- MACD
- WTTR -0.23
- XNCR -0.23
- Stochastic Oscillator
- WTTR 12.64
- XNCR 38.42
About WTTR Select Water Solutions Inc.
Select Water Solutions Inc provides sustainable water and chemical solutions to the energy industry. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. Its reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates the majority of its revenue from Water Services.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.